One company leads in gene-editing approvals, while the other targets surging demand in metabolic treatments. Here’s how their ...

Editorial: Polling shows that the public supports this new technology, but the conversation must move beyond simple questions of safety ...

A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...

A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...

Gene editing donor organs during machine perfusion could rescue more than 28,000 organs discarded annually in the US, per a ...

Casgevy sickle cell gene therapy is now FDA-approved for children as young as two, opening access for 5,500 more U.S. kids.

Research led by the University of Cambridge Loke Centre for Trophoblast Research has shown that a genome editing technique ...

Casgevy also now indicated for transfusion-dependent beta thalassemia in children 2 years ...

Research led by the University of Cambridge Loke Center for Trophoblast Research has shown that a genome-editing technique ...

A new study uses precise base editing on human embryos for the first time, proving the NANOG gene is the master switch for body development.

The inventor of the groundbreaking Crispr gene-editing technology is skeptical about artificial intelligence replacing human ...

The Gene Editing Therapeutics market, driven by advancements in CRISPR technology and precision medicine, presents opportunities in oncology, rare genetic disorders, and chronic diseases. Investment ...